Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1995-05-23
2000-05-23
Feisee, Lila
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241301, 4241411, 4241521, 4241721, A61K 39395
Patent
active
060663219
ABSTRACT:
A novel endothelial cell molecule, VAP-1, is described that mediates lymphocyte binding in man. Further described are anti-VAP-1 monoclonal antibodies and methods for the diagnosis and treatment of inflammatory and autoimmune diseases by the administration of VAP-1 binding compounds, such as anti-VAP-1 antibodies.
REFERENCES:
Airas et al., "Lymphocyte-Vascular Adhesion Protein-2 Is a Novel 70-kDa Molecule Involved in Lymphocyte Adhesion to Vascular Endothelium," J. Immunol. 151(8):4228-4238 Oct. (1993).
Balass et al., "Identification of a hexapeptide that mimics a conformation-dependent binding site of acetylcholine receptor by use of a phage-epitope library," PNAS USA 90:10638-10642 Nov. (1993).
Berg et al., "The Human Peripheral Lymph Node Vascular Addressin is a Ligand for LECAM-1, the Peripheral Lymph Node Homing Receptor," J. Cell. Biol. 114(2):343-349 Jul. (1991).
Bevilacqua et al., "Identification of an inducible endothelial-leukocyte adhesion molecule," PNAS USA 84:9238-9242 Dec. (1987).
Butcher E. C., "Leukocyte-Endothelial Cell Recognition: Three (or More) Steps to Specificity and Diversity," Cell 67:1033-1036 Dec. (1991).
Cotran et al., "Induction and Detection of a Human Endothelial Activation Antigen In Vivo," J. Exp. Med. 164:661-666 Aug. (1986).
de Fougerolles et al., "Characterization of ICAM-2 and Evidence for a Third Counter-Receptor for LFA-1," J. Exp. Med. 174:253-267 Jul. (1991).
Freeman et al., "An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors," PNAS USA 87:8810-8814 Nov. (1990).
Friedman et al., "Cloning and characterization of cyclophilin C-associated protein: A candidate natural cellular ligand for cyclophilin C," PNAS USA 90:6815-6819 Jul. (1993).
Geoffroy et al., "Evidence for a Distinct Lymphocyte Homing Specificity Involved in Lymphocyte Migration to Lung-Associated Lymph Nodes," FASEB J. 2:A667, Abstract No. 2152 (1988).
Harris and Emery, "Therapeutic Antibodies--the coming of age," TiBTECH 11:42-46 Feb. (1993).
Hattori et al., "Stimulated Secretion of Endothelial von Willebrand Factor is Accompanied by Rapid Redistribution to the Cell Surface of the Intracellular Granule Membrane Protein GMP-140," J. Biol. Chem. 264(14):7768-7771 May (1989).
Jalkanen et al., "A Distinct Endothelial Cell Recognition System that Controls Lymphocyte Traffic into Inflamed Synovium," Science 233:556-558 Aug. (1986).
Jalkanen et al., "In Vitro Analysis of the Homing Properties of Human Lymphocytes: Developmental Regulation of Functional Receptors for High Endothelial Venules," Blood 66(3):577-582 Sep. (1985).
Jalkanen et al., "A Novel Endothelial Cell Antigen Involved in Lymphocyte Binding to High Endothelial Venules," Keystone Symp. Mol. Cell. Biol., Suppl. 16F, p. 107, Abstract No. W610 (Apr. 3-16, 1992).
Osborn et al., "Direct Expression Cloning of Vascular Cell Adhesion Molecule 1, A Cytokine-Induced Endothelial Protein that Binds to Lymphocytes," Cell 59:1203-1211 Dec. (1989).
Osborn, L., "Leukocyte Adhesion to Endothelium in Inflammation," Cell 62:3-6 Jul. (1990).
Rice et al., "Vascular and Nonvascular Expression of INCAM-110, A Target for Mononuclear Leukocyte Adhesion in Normal and Inflamed Human Tissues," Amer. J. Pathol. 138(2):385-393 Feb. (1991).
Rosen et al., "Involvement of Sialic Acid on Endothelial Cells in Organ-Specific Lymphocyte Recirculation," Science 228:1005-1007 May (1985).
Salmi and Jalkanen, "A 90-Kilodalton Endothelial Cell Molecule Mediating Lymphocyte Binding in Humans," Science 257:1407-1409 Sep. (1992).
Salmi et al., "A Novel Endothelial Cell Antigen Involved in Lymphocyte Binding to High Endothelial Venules," Eur. Fed. Immunol. Soc. 11th Meeting Abstracts, Abstract No. 21-12 (Jun. 9, 1991).
Salmi et al., "Induction and Function of Vascular Adhesion Protein-1 at Sites of Inflammation," J. Exp. Med. 178:2255-2260 Dec. (1993).
Stoolman, L.M., "Adhesion Molecules Controlling Lymphocyte Migration," Cell 56:907-910 Mar. (1989).
Wellicome et al., "A Monoclonal Antibody that Detects A Novel Antigen on Endothelial Cells that is Induced by Tumor Necrosis Factor, IL-1, or Lipopolysaccharide," J. Immunol. 144(7):2558-2565 Apr. (1990).
Edgington Biotechnology 10:383-389 (1992).
Mountain et al. Biotech. Gen. Eng. Rev. 10: 1,10-13 (1992).
Ward et al Therapeutic Immunol. 1: 165-171 (1994).
Sherman-Gold Gen. Eng. News.sup.13 :6,7,14 (1993).
McCabe et al. Cell. Immunol. 150:364-375 (1993).
Kahan Curr Opin Immunol. 4:553-560 (1992) faxed Jan. 23, 1996 This Kahan Ref.
Jalkanen Sirpa
Salmi Marko
Feisee Lila
Gambel Phillip
LandOfFree
Method for antagonizing vascular adhesion protein-1 (VAP-1)-medi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for antagonizing vascular adhesion protein-1 (VAP-1)-medi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for antagonizing vascular adhesion protein-1 (VAP-1)-medi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1835090